Fig. 1
From: Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey
A Overview of the qualification of the respondents showing the type of patients treated per centre. B Overview of the number of patients with each LCFAOD treated in the different centres. LCFAOD Long chain fatty acid oxidation defects, NBS Newborn screening, VLCADD Very long-chain acyl-CoA dehydrogenase deficiency, CPT2D Carnitine palmitoyltransferase 2 deficiency, LCHADD Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, MTPD Mitochondrial trifunctional protein deficiency